Javier Navarro-Zaragoza Selected Research

CP 154526

1/2012	Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc).
5/2010	Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Navarro-Zaragoza Research Topics

Disease

2	Body Weight (Weight, Body) 01/2012 - 05/2010
1	Drug-Related Side Effects and Adverse Reactions 06/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2022
1	Cardiovascular Abnormalities 12/2021
1	Orthostatic Hypotension (Postural Hypotension) 12/2021
1	Parkinson Disease (Parkinson's Disease) 03/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021
1	Binge Drinking 01/2015
1	Substance-Related Disorders (Drug Abuse) 01/2012

Drug/Important Bio-Agent (IBA)

2	CP 154526IBA 01/2012 - 05/2010
2	Morphine (MS Contin)FDA LinkGeneric 01/2012 - 05/2010
1	Carbamazepine (Tegretol)FDA LinkGeneric 06/2022
1	LithiumIBA 06/2022
1	Levodopa (L Dopa)FDA LinkGeneric 12/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2021
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	Small Heat-Shock ProteinsIBA 03/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2015
1	CRF receptor type 1IBA 01/2012
1	antalarminIBA 05/2010
1	Naloxone (Narcan)FDA LinkGeneric 05/2010